COVID-19 vaccines taken by people with inflammatory bowel disease (IBD), which affects millions worldwide, safely and effectively protect them from the SARS-Cov-2 virus, a Rutgers study finds. The comprehensive review, published in the journal Alimentary Pharmacology & Therapeutics, focused on all studies describing the response of patients with IBD who were administered a COVID-19 vaccine.
An international team of researchers, including four Rutgers astronomers, has discovered a powerful megamaser -- a naturally occurring, astronomical, radio-wavelength laser -- in a galaxy nearly five billion light years from Earth.
Two large genetic studies, recently published in Nature, point to similar genes and biological mechanisms that start to hone in on the root causes of the severe psychiatric disorder.
Two products commonly administered intravenously to replenish iron levels in the body have a much higher chance of provoking a severe allergic attack, according to Rutgers researchers who conducted a study analyzing the medical records in a large database of older, Medicare patients.
Scientists have long puzzled about a critical way that cells communicate with one another, but Rutgers researchers have used a simple roundworm to solve the mystery. The study, which appears in the journal Current Biology, could help to develop treatments for Alzheimer’s and other neurodegenerative diseases.
As we celebrate National Women's History Month, recognizing the social, economic, cultural, and political achievements of women – strides made recently have elevated women to new heights, but a Rutgers University‒Camden scholar says there is a long way to go to overcome gender equality hurdles.
Despite strong evidence that medication is the most effective treatment for opioid use disorder (OUD), adolescents and most adults who might benefit from OUD treatment report no medication use, according to a study by researchers at the Rutgers School of Public Health and Columbia University Mailman School of Public Health.
A Rutgers researcher has received a $1.9 million award from the National Institutes of Health (NIH) to investigate the role of an enzyme in the gut and its potential as a therapy to help lower lipid levels in the blood.
Rutgers Office for Research welcomes Hila Feldman Berger as assistant vice president of research regulatory affairs, starting March 22, 2022. Berger joins Rutgers from Montclair State University where she served as director of research compliance and regulatory programs.
